Press releaseGlobe Newswire
MiMedx Group
MDXG · NASDAQ
$4.23−$0.15 (−3.42%)TodayMarket closed ·
Prev close $4.38
About MDXG
- Employees
- 808
- Headquarters
- Marietta, Georgia
- Listed
- Aug 20, 2007
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- mimedx.com
MDXG key statistics
- Market cap
- 616.57M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.21M
- Volume
- 1.63M
- Open price
- $4.40
- High today
- $4.46
- Low today
- $4.21
- 52 Week high
- $7.97
- 52 Week low
- $3.03
MiMedx Group (MDXG) at a glance
As of Oct 20, 2026, MiMedx Group (MDXG) shares are priced at $4.23, giving the company a market cap of 616.57M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $4.21 and $4.46. The current price is 0.5% above the day's low and 5.2% below its high.
Volume so far is 1.63M shares, above the average of 1.21M shares a day.
Over the past year MiMedx Group has ranged from $3.03 to $7.97, and now sits 24% of the way up that range.
MiMedx Group met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.10 per share against an estimate of -$0.0485.
The average analyst price target is $7.14, 68.8% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 5 analyst ratings say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 7 analystsAvg $7.14
- Low
- $6.06
- Now
- $4.23
- High
- $8.40
MDXG earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 45.3% on average.
- Q3 FY24: reported $0.05 per share against an estimate of $0.0449
- Q4 FY24: reported $0.05 per share against an estimate of $0.0734
- Q1 FY25: reported $0.06 per share against an estimate of $0.0561
- Q2 FY25: reported $0.10 per share against an estimate of $0.0551
- Q3 FY25: reported $0.15 per share against an estimate of $0.0714
- Q4 FY25: reported $0.10 per share against an estimate of $0.0857
- Q1 FY26: reported -$0.07 per share against an estimate of -$0.0281
- Q2 FY26: reported -$0.10 per share against an estimate of -$0.0485
MDXG news
- Press releaseGlobe Newswire
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
- Press releaseGlobe Newswire
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
- Press releasePRNewswire
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
Similar companies
Companies in the same industry as MiMedx Group
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.